COMMUNIQUÉS West-GlobeNewswire

Egg Medical présente EggNest™ Complete Flex : une protection sans tablier, sans travaux, sans interruption de service ni perturbation
06/04/2026
MINNEAPOLIS, 06 avr. 2026 (GLOBE NEWSWIRE) -- Egg Medical annonce le lancement d’EggNest™ Complete Flex, une avancée révolutionnaire en matière de protection contre les radiations qui permet aux cliniciens de travailler [...]
Aveanna Healthcare Announces Second Annual Aveanna Cares Month of Service
06/04/2026
ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare (NASDAQ: AVAH ) today announced the second year of Aveanna Cares, the company’s month-long, team-based volunteer initiative dedicated to giving back to the [...]
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD [...]
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that [...]
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
WEST CHESTER, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
New LockeT Data Accepted in Leading Electrophysiology Journal
06/04/2026
FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention [...]
Sienna Senior Living recognized by The Globe and Mail’s Women Lead Here Benchmark
06/04/2026
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living, one of Canada’s leading owners and operators of senior living communities, has been recognized for the sixth consecutive year in The Globe and [...]
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
06/04/2026
Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Egg Medical Launches EggNest™ Complete Flex: Apron-Free Protection Without Construction, Downtime or Disruption
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Egg Medical announces the launch of EggNest™ Complete Flex, a groundbreaking advancement in radiation protection that enables clinicians to safely work apron-free or with [...]
TOMI Environmental Solutions, Inc. Announces Surge in SteraMist Adoption Across Compounding Pharmacy Industry Amid Tightening Regulatory Standards
06/04/2026
SteraMist iHP Expansion into Compounding 503A and 503B Pharmacies FREDERICK, Md., April 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and [...]
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare [...]
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
06/04/2026
FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) [...]
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
06/04/2026
HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering of 11,896,750 [...]
Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN
06/04/2026
CHARLOTTE, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
CLEVELAND, April 06, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved [...]
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
SAN MATEO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy
06/04/2026
Elsunersen demonstrated placebo-adjusted seizure reduction from baseline of 77% (p=0.015) 71% of elsunersen-treated patients achieved >50% seizure reduction by period 6, with sustained benefit observed in the open- [...]
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 06 April 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” [...]
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today announced an extension to its Series B financing, bringing the funding round to $97 million and the company’s cumulative funding to over $132 million. [...]

Pages